This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

nileshsha@hotmail.com
This is why Merck is buying Cidara Therapeutics for .2 billion, and why Wall Street is happy



This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy
Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.


www.marketwatch.com
#Merck #buying #Cidara #Therapeutics #billion #Wall #Street #happy

Related reading:
Share: X · Facebook · LinkedIn

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *